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1. Introduction 
Multimorbidity is usually defined as the co-occurrence of two or more long term conditions 
within one individual, and is an increasing problem with a reported doubling of prevalence over the 
last 20 years [1]. It is a global phenomenon and has now become the norm rather than exception in 
many populations [2–5]. Multimorbidity is associated with increased mortality [6–8], lower quality of 
life [9–11], and greater utilization of healthcare including unplanned admissions [12–14] and thus higher 
healthcare costs [6,15–17]. Patients with multimorbidity are less satisfied with care provided [18], perhaps 
due to the fragmentation of care resulting from the single disease-focus that drives much of current 
health care [19–21]. 
 
The prevalence of multimorbidity rises rapidly with increasing age [4–6,16,22–24], although, the 
absolute number of individuals with multimorbidity is often higher in those under 65 years [4,25,26]. 
It is also strongly associated with socioeconomic deprivation and occurs 10–15 years earlier in 
individuals living in the most deprived compared with the least deprived areas [3–5]. The effect of sex 
on multimorbidity has been less well defined [3]. Most previous studies have shown an increased 
prevalence of multimorbidity among women [1,6,16,26], though not all studies find  
this [2,27,28]. Although in almost all countries in the world women have a longer life expectancy than 
men [29], they are more often affected by a number of non-fatal chronic diseases that decrease quality 
of life and everyday physical ability [23,30]. 
Multimorbidity is a broad concept, and can be characterised further in a number of ways, such as 
physical-only, mental-only, and mixed mental and physical [24], as well as by the commonest 
combinations of individual conditions. The typology of multimorbidity by sex has not been well 
documented in large primary care populations. Therefore, this study aimed to examine the 
relationship between sex and different types of multimorbidity across different age groups, using 
cross-sectional data from a nationally representative large primary care dataset. 
2. Methods 
We obtained a dataset for 1,751,841 patients of all ages, who were alive on 31 March 2007 and 
permanently registered with 314 Scottish general practices, from the Primary Care Clinical 
Informatics Unit at the University of Aberdeen, UK [31]. This accounts for about a third of the Scottish 
population and is representative of it in terms of age, sex, and socioeconomic deprivation. The NHS 
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National Research Ethics Service had previously approved the use of these anonymised data for 
research purposes and this analysis did not require independent review [4]. 
Forty conditions in total were analysed as previously defined [4] using either Quality and 
Outcomes Framework (QOF) register Read Code sets where available (Read Codes are the clinical 
coding system used in UK general practice) [32], other Read Code sets used by NHS Scotland for non-
QOF conditions, or combinations of Read Codes and prescription data where coding was known to be 
likely to under-record important conditions. The appendix provides further detail of definitions and the 
40 conditions analysed. 
Multimorbidity was defined as the presence of two or more disorders in an individual. The 
choice of conditions was based on recommendations from systematic review for multimorbidity 
measure [33] as well as diseases in QOF within UK General Practice (GP) contract and important 
diseases identified by NHS Scotland [32,34]. To specifically examine multimorbidity in terms of 
physical and mental health disorders, we defined each condition as either a physical or mental health 
disorder. Of the 40 conditions we classified 32 as physical and 8 as mental disorders (depression, 
anxiety, drugs misuse, alcohol misuse, schizophrenia/bipolar, dementia, learning disability and 
anorexia). 
In order to characterize the prevalence and type of multimorbidity, we additionally analysed 
how many people had: (a) 2 or more physical conditions but no mental health conditions (physical-
only); (b) 2 or more mental health conditions but no physical conditions (mental-only); or (c) 2 or 
more conditions including at least 1 physical and 1 mental (mixed physical and mental). We then 
examined the top 10 most common conditions in those with multimorbidity separately in each age 
group by sex. 
 
As the current analysis focused on adults with multimorbidity, we excluded adults aged under 25 
years in whom multimorbidity is uncommon (prevalence 1.9%) [4]. We divided the remaining 
patients into 6 age groups (25–34, 35–44, 45–54, 55–64, 65–74 and 75 and over) to reflect different 
stages in the life course. For each of these age groups, we calculated the number (and percentage) of 
patients with: no conditions; with one condition; and with two or more conditions. We used graphical 
display to compare differences by age group in patterns of multimorbidity by sex. We calculated the 
ten most prevalent conditions by age group and separately for men and women with two or more 
conditions by dividing the number of patients with each condition by the number of patients in the 
relevant age groups with two or more conditions. All analysis was conducted using Stata version 
13.0. 
 
3. Results 
The analysis involved 1,272,685 adults aged 25 years and over, of whom 51% were women and 
49% were men. Table 1 shows differences in prevalence of morbidity by age group and sex. For both 
men and women, the number and percentage of people with multimorbidity was higher in each 
successive ten-year age group within each sex, however, there were more people with multimorbidity 
in absolute numbers under the age of 65 (201,311 vs. 194,996). There were more women with 
multimorbidity than with a single condition or no condition in all age groups above the age of 55, 
whereas this was only true in men above the age of 65. The prevalence of multimorbidity (two or 
more conditions) was higher in women than in men in every age group, although the differences 
were small over the age of 65. The biggest sex difference was found in the 45–54 age group (women 
26.5% vs. men 19.6%; difference 6.9 (95% CI 6.5 to 7.2). 
Table 2 shows the prevalence of different types of multimorbidity (physical or mental or mixed) 
across age groups by sex. In general, the differences in prevalence of all types of multimorbidity 
between men and women were markedly small. However, whilst physical-only morbidity increased 
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with age for both men and women, differences were small up to the age of 64 years but were 
marginally higher for women. After the age of 65 more men than women had physical-only 
multimorbidity. The most significant difference was observed in the over 75 age group (women 45.3% 
vs. men 53.5%; difference −8.3 (95% CI −7.7 to −8.7). Gender differences were greatest for mixed 
physical and mental multimorbidity (as compared with mental-only and physical-only) at all ages but 
the magnitude of this difference varied with age. Women’s higher prevalence of mixed physical and 
mental multimorbidity was small in absolute terms at age 25–34 (2.1% (95% CI 1.9 to 2.2), increasing 
to around 5% between the ages 45 and 74), and highest in those above the age of 75 (women 30.9% vs. 
men 21.2%; difference 9.7 (95% CI 9.1 to 10.2). 
Figure 1 shows the number of people with the different types of multimorbidity by age group 
and sex. It illustrates that, overall, women have more multimorbidity across the life course but sex 
differences are small and diminish even more after 55–64 years. It shows that a large part of this 
reduction in sex difference is due to a steeper rise in the prevalence of men with physical only 
multimorbidity compared to women. 
Table 3 shows prevalence (%) of the conditions which feature in the top 10 most commonly 
found in men or women with multimorbidity within each age group. For women with 
multimorbidity below the age of 55, depression was the condition with the highest prevalence, 
whereas above the age of 55 hypertension was the most common condition. In contrast for men with 
multimorbidity, drugs misuse had the highest prevalence for men aged 25–34, depression for men 
aged 35–44, and hypertension for men aged 45 and over. Women had a consistently higher prevalence 
of depression, pain, IBS and thyroid disorders across all age groups. For men under 45 with 
multimorbidity, compared to women in the same age group, prevalence was only notably higher for 
substance (alcohol and drugs) misuse. Amongst people with multimorbidity, higher prevalence’s of 
coronary heart disease (CHD) and diabetes were recorded in men than women from the ages of 45 
and over. 
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Table 1. Number of conditions by age group and sex. 
Age 
Group 
No Conditions One Condition Two Conditions 
Women 
No. (%) 
Men 
No. 
(%) 
Difference 
(95% CI) 
Women 
No. (%) 
Men 
No. 
(%) 
Difference 
(95% CI) 
Women 
No. (%) 
Men 
No. 
(%) 
Difference 
(95% CI) 
25–34 
78,941 
(70.1) 
90,806 
(77.7) 
−7.6 (−7.2 to 
−7.9) 
22,701 
(20.2) 
18,261 
(15.6) 
4.6 (4.2 to 
4.9) 
10,911 
(9.7) 
7776 
(6.7) 
3.0 (2.8 to 
3.2) 
35–44 
80,309 
(58.9) 
99,029 
(69.4) 
−10.5 (−10.1 
to −10.8) 
32,966 
(24.1) 
27,805 
(19.5) 
4.6 (4.3 to 
5.0) 
23,025 
(16.9) 
15,859 
(11.1) 
5.8 (5.5 to 
6.0) 
45–54 
59,328 
(47.3) 
72,592 
(56.4) 
−9.1 (−8.7 to 
−9.5) 
32,751 
(26.1) 
30,702 
(23.9) 
2.2 (1.9 to 
2.5) 
33,230 
(26.5) 
25,191 
(19.6) 
6.9 (6.5 to 
7.2) 
55–64 
35,128 
(31.9) 
40,715 
(37.2) 
−5.3 (−4.8 to 
−5.7) 
29,120 
(26.4) 
29,051 
(26.6) 
−0.2 (0.2 to 
−0.4) 
45,737 
(41.6) 
39,582 
(36.2) 
5.4 (4.9 to 
5.7) 
65–74 
14,868 
(18.0) 
13,794 
(18.9) 
−0.9 (−0.5 to 
−1.2) 
18,567 
(22.5) 
16,501 
(22.7) 
−0.2 (0.2 to 
−0.5) 
49,009 
(59.4) 
42,541 
(58.0) 
1.4 (0.5 to 
1.5) 
75 plus 6989 (8.3) 
4864 
(9.4) 
−1.1 (−0.7 to 
−1.3) 
12,532 
(14.9) 
8058 
(15.5) 
−0.6 (−0.1 to 
−1.0) 
64,491 
(76.7) 
38,955 
(75.1) 
1.6 (1.2 to 
2.1) 
Analysis based on 40 chronic conditions; 32 physical and 8 mental, percentages in the conditions columns relate 
distribution within each separate age group by sex. 
Table 2. Differences in type of multimorbidity by age group and sex. 
Age 
Group 
Physical Only Multimorbidity Mental Only Multimorbidity Mixed Physical and Mental Multimorbidity 
Women 
No. (%) 
Men 
No. (%) 
Difference 
(95% CI) 
Women 
No. (%) 
Men 
No. (%) 
Differenc
e  
(95% CI) 
Women 
No. (%) 
Men 
No. (%) 
Differenc
e  
(95% CI) 
25–34 3185 (2.8) 
1925 
(1.6) 
1.2 (1.0 to 
1.3) 
1847 (1.6) 
2172 
(1.8) 
−0.2 (−0.1 
to −0.3) 
5879 (5.2) 
3679 
(3.1) 
2.1 (1.9 to 
2.2) 
35–44 7785 (5.7) 
5455 
(3.8) 
1.9 (1.7 to 
3.0) 
2367 (1.7) 
2620 
(1.8) 
−0.1 (−0.0 
to −0.2) 
12,873 
(9.4) 
7784 
(5.5) 
3.9 (3.7 to 
4.1) 
45–54 
13,999 
(11.1) 
12,643 
(9.8) 
1.3 (1.1 to 
1.5) 1659 (1.3) 
1479 
(1.1) 
0.2 (0.0 to 
0.3) 
17,572 
(14.0) 
11,069 
(8.6) 
5.4 (5.1 to 
5.7) 
55–64 
25,175 
(22.9) 
24,596 
(22.5) 
0.4 (0.0 to 
0.7) 
891 (0.08) 
735 
(0.07) 
0.01 (0.00 
to 0.06) 
19,671 
(17.9) 
14,251 
(13.0) 
4.9 (4.5 to 
5.1) 
65–74 
31,711 
(38.5) 
30,825 
(42.3) 
−3.8 (−3.3 to 
−4.3) 
420 (0.05) 
245 
(0.03) 
0.02 (0.01 
to 0.03) 
16,878 
(20.5) 
11,471 
(15.7) 
4.8 (4.3 to 
5.1) 
75 plus 
38,088 
(45.3) 
27,824 
(53.5) 
−8.3 (−7.7 to 
−8.7) 
459 (0.05) 
127 
(0.02) 
0.03 (0.02 
to 0.04) 
25,944 
(30.9) 
11,004 
(21.2) 
9.7 (9.1 to 
10.2) 
Analysis based on 40 chronic conditions; 32 physical and 8 mental. Percentages are the % in each age group by 
sex. 
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Table 3. Differences by age and sex in the top 10 most prevalent conditions for multimorbid patients. 
Rank Order of 
Conditions 
Age 25–34 
(Women)  
% (95% CI)  
n = 10,911 
Age 25–34 (Men)  
% (95% CI)  
n = 7,776 
Age 35–44 (Women)  
% (95% CI)  
n = 23,025 
Age 35–44 (Men)  
% (95% CI)  
n = 15,859 
Age 45–54 (Women)  
% (95% CI)  
n = 33,230 
Age 45–54 (Men)  
% (95% CI)  
n = 25,191 
1 
Depression  
52.9 (51.9–53.8) 
Drugs Misuse  
38.5 (37.4–39.6) 
Depression  
53.7 (53.1–54.3) 
Depression  
36.9 (36.1–37.7) 
Depression  
46.5 (46.0–47.0) 
Hypertension  
36.0 (35.4–36.6) 
2 
Asthma  
27.6 (26.8–28.4) 
Depression  
36.4 (35.3–37.4) 
Pain  
28.4 (27.8–29.0) 
Pain  
23.5 (22.8–24.1) 
Pain  
32.0 (31.5–32.5) 
Depression  
28.5 (27.9–28.0) 
3 
Pain  
21.4 (20.6–22.1) 
Alcohol dependence  
22.8 (21.8–23.7) 
Asthma  
22.6 (22.0–23.1) 
Drugs Misuse  
22.4 (21.8–23.1) 
Hypertension  
27.0 (26.5–27.5) 
Pain  
26.4 (25.9–26.9) 
4 
IBS  
19.9 (19.1–20.6) 
Asthma  
22.1 (21.1–23.0) 
IBS  
20.2 (19.7–20.7) 
Alcohol dependence  
21.8 (21.2–22.4) 
Thyroid  
19.5 (19.1–19.9) 
Alcohol dependence  
19.0 (18.5–19.5) 
5 
Anxiety  
19.5 (18.7–20.2) 
Anxiety  
20.4 (19.5–21.3) 
Anxiety  
18.2 (17.7–18.7) 
Asthma  
19.2 (18.6–19.8) 
Asthma  
18.7 (18.3–19.1) 
Dyspepsia  
18.9 (18.4–19.4) 
6 
Drugs Misuse  
16.9 (16.1–17.6) 
Pain  
16.0 (15.1–16.7) 
Thyroid  
15.7 (15.2–16.1) 
Dyspepsia  
19.1 (18.4–19.7) 
Dyspepsia  
18.1 (17.7–18.5) 
Diabetes  
17.8 (17.3–18.3) 
7 
Thyroid  
11.0 (10.3–11.5) 
Dyspepsia  
12.4 (11.6–13.1) 
Dyspepsia  
14.6 (14.1–15.1) 
Anxiety  
17.2 (16.6–19.8) 
IBS  
17.8 (17.4–18.2) 
Asthma  
14.4 (14.0–14.8) 
8 
Dyspepsia  
9.0 (8.5–9.5) 
Schizophren/Bi-polar  
8.8 (8.1–9.4) 
Hypertension  
11.6 (11.2–12.0) 
Hypertension  
16.6 (16.0–17.2) 
Anxiety  
15.5 (15.0–15.8) 
Inflammatory arthritis  
12.6 (12.2–13.0) 
9 
Alcohol 
dependence  
8.6 (8.1–9.1) 
Hearing loss  
7.9 (7.3–8.5) 
Drugs Misuse  
9.5 (9.1–9.8) 
Diabetes  
10.5 (10.0–11.0) 
Diabetes  
10.7 (10.4–11.0) 
Anxiety  
11.2 (10.8–11.6) 
10 
Hearing loss  
6.2 (3.2–4.0) 
IBS  
6.7 (6.1–7.3) 
Alcohol dependence  
7.4 (7.1–7.7) 
IBS  
8.0 (7.6–8.4) 
Inflammatory arthritis  
9.5 (9.2–9.8) 
CHD  
10.9 (10.5–11.3) 
Rank order of 
conditions 
Age 55–64 
(Women)  
% (95% CI)  
n = 47,727 
Age 55–64 (Men)  
% (95% CI)  
n = 39,852 
Age 65–74 (Women)  
% (95% CI)  
n = 49,009 
Age 65–74 (Men)  
% (95% CI)  
n = 42,541 
Age 75&over (Women)  
% (95% CI)  
n = 64,491 
Age 75& over (Men)  
% (CI 95%)  
n = 38,955 
1 
Hypertension  
46.6 (46.1–47.0) 
Hypertension  
50.8 (50.3–51.2) 
Hypertension  
59.3 (58.8–59.7) 
Hypertension  
57.1 (56.7–57.6) 
Hypertension  
64.4 (64.0–64.7) 
Hypertension  
57.9 (57.3–58.4) 
2 
Depression  
34.7 (34.2–35.1) 
Pain  
27.8 (27.4–28.2) 
Pain  
33.5 (33.0–33.9) 
CHD  
33.2 (32.8–33.7) 
CHD  
26.6 (26.3–26.9) 
CHD  
38.8 (38.2–39.2) 
3 
Pain  
34.5 (34.0–34.9) 
CHD  
22.2 (21.8–22.6) 
Depression  
23.5 (23.2–23.9) 
Pain  
25.9 (25.5–26.4) 
Pain  
26.3 (26.0–26.6) 
Diabetes  
19.9 (19.5–20.3) 
4 
Thyroid  
21.8 (21.4–22.2) 
Diabetes  
21.8 (21.3–22.3) 
Thyroid  
22.4 (22.1–22.8) 
Diabetes  
24.1 (23.7–24.5) 
Thyroid  
21.5 (21.2–21.8) 
Stroke-TIA  
19.2 (18.8–19.5) 
5 Dyspepsia  Depression  CHD  COPD  Depression  Pain  
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18.5 (18.1–18.8) 20.3 (19.9–20.7) 19.9 (19.6 –20.3) 15.1 (14.8–15.4) 20.7 (20.4–21.0) 19.1 (18.7–19.5) 
6 
Asthma  
14.7 (14.3–15.0) 
Dyspepsia  
15.6 (15.2–16.0) 
Diabetes  
18.4 (18.1–18.8) 
Inflammatory arthritis  
14.1 (13.8–14.5) 
Chronic Kidney Disease  
19.4 (19.1–19.7) 
Hearing Loss  
18.0 (17.6–18.4) 
7 
Diabetes  
14.2 (13.9–14.5) 
Alcohol dependence  
14.6 (14.3–14.9) 
Dyspepsia  
18.0 (17.7–18.4) 
Dyspepsia  
13.5 (13.1–13.8) 
Constipation  
18.0 (17.7–18.3) 
Chronic Kidney Disease  
16.8 (16.5–17.1) 
8 
Irritable bowel 
syndrome  
13.3 (13.0–13.6) 
Inflammatory arthritis  
 14.3 (14.0–14.6) 
COPD  
14.2 (13.9–14.5) 
Stroke-TIA  
12.9 (12.6–13.2) 
Dyspepsia  
16.4 (16.1–16.7) 
COPD  
16.6 (16.2–16.9) 
9 
Anxiety  
13.1 (12.8–13.4) 
COPD  
10.7 (10.4–11.0) 
Inflammatory arthritis  
13.4 (13.0–13.84 
Depression  
12.7 (12.4–13.0) 
Anxiety  
15.9 (15.6–16.1) 
Any Cancer  
15.5 (15.1–15.8) 
10 
Inflammatory 
poly-arthropathy  
12.5 (12.2–12.8) 
Asthma  
10.2 (9.9–10.5) 
Anxiety  
13.1 (12.8–13.4) 
Hearing Loss  
12.2 (11.8–12.5) 
Diabetes  
15.5 (15.2–15.8) 
Constipation  
15.2 (14.8–15.5) 
Abbreviations: Coronary Heart Disease (CHD); Chronic obstructive pulmonary disease (COPD); Irritable bowel syndrome (IBS). 
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Figure 1. Per cent of people, by type of multimorbidity (physical only, mental only and mixed) and by 
sex and age. 
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4. Discussion 
This study has examined patterns of multimorbidity by age and sex in 1,272,685 adults in a 
nationally representative primary care sample in Scotland. Women had more overall multimorbidity 
than men at all ages, although the sex differences were relatively small. From the age of 45, physical-
only multimorbidity was consistently more common in men, and physical-mental multimorbidity 
more common in women. The biggest sex difference in physical-mental multimorbidity was found in 
the 75 years and over group. The commonest condition in women was depression until the age of 55 
years, thereafter hypertension. Depression, pain, irritable bowel syndrome and thyroid disorders 
were more common in women than men across all age groups. 
4.1. Relationship with Existing Literature 
Several studies have reported that women have more multimorbidity than men [4,26,35], as 
reflected in a recent systematic review [3]. The level of sex difference in multimorbidity varies 
between studies. One study reported little difference between the sexes on the risk of being 
mutlimorbid [36]. This study used 20 chronic conditions and the difference in reported results may be 
explained by the inclusion in our study of additional conditions which are far more prevalent in 
women such as migraine and thyroid diseases. Moreover, most previous studies have had either 
much smaller samples sizes [26,27,36,37] or were restricted to elderly [38,39,40] or hospitalised people 
[41], whereas the current study examined a nationally representative one-third of the Scottish 
population. 
As far as we are aware, our study is the first to show prevalence rates of different types of 
multimorbidity and particular conditions by sex and across all ages in a large, nationally 
representative dataset. 
In terms of mental health morbidity, our results show that physical-mental multimorbidity is 
much more common in women than men. Depression was more prevalent in women than men and 
was the most frequently occurring condition among women below the age of 55. These findings agree 
with previously published studies in both multimorbid [4,42] and single disease analyses. [43] 
Whether this reflects “true” levels of depression in patients with at least one other condition, or a 
difference in the presentation (by patients) or recognition (by patients and doctors) of depression in 
people with other long-term conditions cannot be determined from these data. Experimental studies 
support differential recognition by doctors of potential symptoms in women and men [44–46], at least 
for cardiovascular disease and depression. In addition, below the ages of around 60 years, women are 
more likely to have contact with their general practitioner [47], and there thus may be differences 
between men and women of prior recording of depression which may alert GPs to be more alert to 
depression when they see female patients with physical conditions. Recent survey data have shown 
that 90% of women with depression discussed it with their doctor [48]. Underestimation of 
depression in men could perhaps also be explained by so called ‘masculine’ ways of responding to 
negative affect, less help seeking and lack of consideration for some of such symptoms in commonly 
used diagnostic tools for depression [49]. This may be important particularly in older populations as 
previous literature has described that depression is related to negative outcomes within chronic 
diseases such as, e.g., coronary heart disease [50]. 
We also found higher rates of alcohol misuse for men with multimorbidity, particularly in the 
younger age groups, which have also been reported elsewhere [51,52]. This is perhaps not surprising 
given the consistent finding of higher consumption of alcohol in general population samples of men 
compared with women in many cultures [53]. It is also consistent with the view that men’s mental 
distress and depressive illness may disproportionately present as substance abuse [54,55]. 
Although we did not examine the utilization of healthcare in the current study, increased 
multimorbidity among female patients, especially those with mental health problems, could explain 
the previous results in literature in relation to consultation rates and emergency inpatient admissions 
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[12,47]. A recent study using a large dataset in England reported that consultation rate among women 
was higher than men, which was only partially explained by reproduction related visits [47]. 
4.2. Strengths and Limitations 
As far as we are aware, the present study represents the most comprehensive study to date on 
sex associations with multimorbidity, based as it is on a large nationally representative primary care 
sample. The study has, however, several limitations. Firstly, it was based on electronic medical 
records from GP practices and thus relies on the diligence of the practitioners in coding conditions, 
and their propensity to do this equally diligently by sex for all conditions. We used mixtures of 
morbidity codes and prescribing to define and measure some conditions, firstly to ensure that coded 
conditions were still “active” (e.g., asthma code plus recent inhaler prescription) and secondly 
because some conditions not incentivised in the UK GPs Quality and Outcomes Framework (such as 
osteoarthritis) are poorly recorded. In addition, the physical conditions we used did not include 
chronic conditions that are specific to women (in order to compare men and women across 
conditions). The study is also not able to take account of severity of any of the conditions as these data 
were not available. Additionally, we did not examine ethnic differences in multimorbidity. 
4.3. Implications for Policy and Practice 
This study shows that multimorbidity differs between men and women in terms of types of 
conditions as well as prevalence, raising the potential need for a more tailored gendered approach to 
patients with multiple chronic conditions. 
Lack of appropriate guidelines and integrated health systems creates a gap between patients’ 
healthcare needs and experiences and its provision [55]. As reflected in previous studies, this gap 
could be decreased by improved integration and a generalist patient-centred approach [56]. Given the 
apparently large additional multimorbidity burden in women relating to sex-specific conditions, 
Gender sensitive services development may be important in some settings, including the 
implementation of sex related health and socio-economic risk factors reduction policies as suggested 
by WHO [57,58] 
Further research is required to understand the differing burdens and impacts of multimorbidity 
typologies in men and women. 
5. Conclusions 
Our study has shown that, overall, women have more multimorbidity across all age groups, 
which is driven by a higher prevalence of combined physical and mental multimorbidity in women 
than men, with the biggest difference in this category being found among the oldest (above the age of 
75 year). This warrants further study, including the severity, burden and effects of such sex 
differences in multimorbidity. 
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